920P - VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients in the thalidomide era

Autor: Lopes-Aguiar, L., Delamain, M.T., Brito, A.B.C., Lourenço, G.J., Costa, E.F.D., Oliveira, G.B., Vassallo, J., De Souza, C.A., Lima, C.S.P.
Zdroj: In Annals of Oncology 1 October 2016 27 Supplement 6:vi317-vi317
Databáze: ScienceDirect